Pharmaceutical Technology

MARCH 17, 2023

Companies are testing the use of digital platforms along with pharmacological treatments. But while appealing, the prospects of developing a merged approach that combines both digital and pharmacological therapeutics remain challenging. Digital therapeutics can be also categorised based on their regulatory journey.

Prescription 111

Prescription Pharmacology Pharma Medical 111

MedCity News

JUNE 16, 2023

The consensus is 2022 was a challenging year for digital health companies. billion in 2022 — down 56% from $40.2 billion in 2022 — down 56% from $40.2 Rather, 2022 represents an overdue correction in the midst of global economic uncertainty after a period of overexuberance and lofty expectations in digital health.

Pharma 108

Pharma Food and Drug Administration Recruitment Patients 108

European Pharmaceutical Review

JULY 4, 2024

1 For use as prescription drugs, a botanical product must be approved by the FDA: to date, only two have gained this approval. The MA pathway is applicable for herbal medicines designed to treat more serious health conditions and require a medical prescription or the supervision of a medical practitioner. 2012/1916).

Marketing 103

Marketing Food and Drug Administration Medicine Prescription 103

European Pharmaceutical Review

APRIL 13, 2023

Australia recently re-classified MDMA and psilocybin to allow prescription of MDMA for the treatment of post-traumatic stress disorder and psilocybin for treatment-resistant depression by psychiatrists. Pharmacological Reviews. World Health Organization; 2022 [cited 2023Mar]. References Nichols DE. Psychedelics.

Medicine 131

Medicine Food and Drug Administration Doctors Medical 131

Pharmaceutical Technology

AUGUST 8, 2022

The digital pill, now marketed by Otsuka Pharmaceuticals, is forecasted to make $27 million in sales in 2022, as per GlobalData. But the pharmacology to quantify adherence also depends on race, gender, weight, and other factors. Despite the fanfare associated with Abilify MyCite, it did not prove to be an attractive proposition.

Food and Drug Administration 122

Food and Drug Administration FDA Medicine Patients 122